Siirry päänavigointiin Siirry hakuun Siirry pääsisältöön

Gastrointestinal Infections Modulate the Risk for Insulin Autoantibodies as the First-Appearing Autoantibody in the TEDDY Study

  • Maria Lonnrot*
  • , Kristian F. Lynch
  • , Marian Rewers
  • , Åke Lernmark
  • , Kendra Vehik
  • , Beena Akolkar
  • , William Hagopian
  • , Jeffrey Krischer
  • , Rickhard A. McIndoe
  • , Jorma Toppari
  • , Anette G. Ziegler
  • , Joseph F. Petrosino
  • , Richard Lloyd
  • , Heikki Hyoty
  • , on behalf of the TEDDY Study Group
  • *Tämän työn vastaava kirjoittaja

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

10 Sitaatiot (Scopus)
75 Lataukset (Pure)

Abstrakti

OBJECTIVE To investigate gastrointestinal infection episodes (GIEs) in relation to the appear-ance of islet autoantibodies in The Environmental Determinants of Diabetes in the Young (TEDDY) cohort. RESEARCH DESIGN AND METHODS GIEs on risk of autoantibodies against either insulin (IAA) or GAD (GADA) as the first-appearing autoantibody were assessed in a 10-year follow-up of 7,867 children. Stool virome was characterized in a nested case-control study. RESULTS GIE reports (odds ratio [OR] 2.17 [95% CI 1.39–3.39]) as well as Norwalk viruses found in stool (OR 5.69 [1.36–23.7]) at <1 year of age were associated with an increased IAA risk at 2–4 years of age. GIEs reported at age 1 to <2 years correlated with a lower risk of IAA up to 10 years of age (OR 0.48 [0.35–0.68]). GIE reports at any other age were associated with an increase in IAA risk (OR 2.04 for IAA when GIE was observed 12–23 months prior [1.41–2.96]). Impacts on GADA risk were limited to GIEs <6 months prior to autoantibody development in children <4 years of age (OR 2.16 [1.54–3.02]). CONCLUSIONS Bidirectional associations were observed. GIEs were associated with increased IAA risk when reported before 1 year of age or 12–23 months prior to IAA. Nor-walk virus was identified as one possible candidate factor. GIEs reported during the 2nd year of life were associated with a decreased IAA risk.

AlkuperäiskieliEnglanti
Sivut1908-1915
Sivumäärä8
JulkaisuDiabetes Care
Vuosikerta46
Numero11
DOI - pysyväislinkit
TilaJulkaistu - 2023
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Rahoitus

Acknowledgments. The authors thank Sarah Austin-Gonzalez with the Health Informatics Institute at the University of South Florida for assistance with editing and preparing the graphical abstract. The authors especially acknowledge the TEDDY families for continued participation in this wonderful study. Funding. The TEDDY study is funded by National Institute of Diabetes and Digestive and Kidney Diseases grants U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, U01 DK124166, and U01 DK128847 and contract HHSN267200700014C and by the National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, Centers for Disease Control and Prevention, and JDRF. This work is also supported in part by the National Institutes of Health/National Center for Advancing Translation Science clinical and translational science awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR002535).

RahoittajatRahoittajan numero
National Institutes of Health
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases
National Institute of Diabetes and Digestive and Kidney DiseasesU01 DK128847, UC4 DK117483, UC4 DK95300, U01 DK63790, UC4 DK100238, UC4 DK106955, U01 DK63821, UC4 DK63865, UC4 DK63836, U01 DK63829, HHSN267200700014C, UC4 DK112243, U01 DK124166, UC4 DK63861, UC4 DK63863
National Institute of Environmental Health Sciences
National Center for Advancing Translational SciencesUL1 TR000064
Juvenile Diabetes Research Foundation United States of America
Eunice Kennedy Shriver National Institute of Child Health and Human Development
University of ColoradoUL1 TR002535

    YK:n kestävän kehityksen tavoitteet

    Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

    1. SDG 3 – Hyvä terveys ja hyvinvointi
      SDG 3 – Hyvä terveys ja hyvinvointi

    Julkaisufoorumi-taso

    • Jufo-taso 3

    !!ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Advanced and Specialised Nursing

    Sormenjälki

    Sukella tutkimusaiheisiin 'Gastrointestinal Infections Modulate the Risk for Insulin Autoantibodies as the First-Appearing Autoantibody in the TEDDY Study'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

    Siteeraa tätä